Advertisement

 

 

IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury.

IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury.
Author Information (click to view)

Thaney VE, O'Neill AM, Hoefer MM, Maung R, Sanchez AB, Kaul M,


Thaney VE, O'Neill AM, Hoefer MM, Maung R, Sanchez AB, Kaul M, (click to view)

Thaney VE, O'Neill AM, Hoefer MM, Maung R, Sanchez AB, Kaul M,

Advertisement

Scientific reports 2017 04 207() 46514 doi 10.1038/srep46514

Abstract

Infection with human immunodeficiency virus-1 (HIV-1) causes brain injury. Type I interferons (IFNα/β) are critical mediators of any anti-viral immune response and IFNβ has been implicated in the temporary control of lentiviral infection in the brain. Here we show that transgenic mice expressing HIV-1 envelope glycoprotein 120 in their central nervous system (HIVgp120tg) mount a transient IFNβ response and provide evidence that IFNβ confers neuronal protection against HIVgp120 toxicity. In cerebrocortical cell cultures, neuroprotection by IFNβ against gp120 toxicity is dependent on IFNα receptor 1 (IFNAR1) and the β-chemokine CCL4, as IFNAR1 deficiency and neutralizing antibodies against CCL4, respectively, abolish the neuroprotective effects. We find in vivo that IFNβ mRNA is significantly increased in HIVgp120tg brains at 1.5, but not 3 or 6 months of age. However, a four-week intranasal IFNβ treatment of HIVgp120tg mice starting at 3.5 months of age increases expression of CCL4 and concomitantly protects neuronal dendrites and pre-synaptic terminals in cortex and hippocampus from gp120-induced damage. Moreover, in vivo and in vitro data suggests astrocytes are a major source of IFNβ-induced CCL4. Altogether, our results suggest exogenous IFNβ as a neuroprotective factor that has potential to ameliorate in vivo HIVgp120-induced brain injury.

Submit a Comment

Your email address will not be published. Required fields are marked *

eighteen − fifteen =

[ HIDE/SHOW ]